Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database

BACKGROUND: Diclofenac, a nonsteroidal anti-inflammatory drug, is not a documented cause of rhabdomyolysis in the Summaries of Product Characteristics held by major regulators. There are, however, eight published single case reports that associate rhabdomyolysis with diclofenac. OBJECTIVE: Triggered...

Descripción completa

Detalles Bibliográficos
Autores principales: Russom, Mulugeta, Fitsum, Yodit, Abraham, Abiel, Savage, Ruth L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324666/
https://www.ncbi.nlm.nih.gov/pubmed/33786776
http://dx.doi.org/10.1007/s40801-021-00240-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324666/
https://www.ncbi.nlm.nih.gov/pubmed/33786776
http://dx.doi.org/10.1007/s40801-021-00240-z

Ejemplares similares